Stock UniverseDerived research view · source repositories remain read-only

Sarepta Therapeutics, Inc. (SRPT)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Qualified
Selection Score
37.75
Global Rank
755
Market Cap
1.76B
Latest Close
15.75
RS Composite
-26.57% · G#2919

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-31.61%
3M
-5.75%
6M
-27.88%
1Y
-60.17%
3Y
-87.26%
5Y
-79.18%
10Y
-24.75%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 2.73M · 30-day average: 2.99M · Max drawdown over stored range: -93.33%

Research Snapshot

Relative Strength vs SPX

RS Composite-26.57%
20D RS-24.91%
60D RS-19.38%
120D RS-34.58%
Global RS Rank2919 · 13.00% percentile
Qualified+ RS Rank1128 · 10.33% percentile
Group ScopeQualified+
Primary RS Rank345 · 24.67% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank119 / 701
Primary Percentile83.17
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-05-061.58Bn/a-40.96M65.06M0.60-730.26M179.50M-909.76M108Mn/a-2.59%4.11%-46.12%-57.46%653.19M838.16M

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$0.6026.2x$14.611.1x$-8.39-1.9x$-6.74-2.3x

Shares Diluted: 108M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue540.099701.887933.0131243.3361901.9792198.237
Revenue Growth (YoY)41.82%29.955%32.929%33.26%52.974%15.576%
Gross Profit-245.526-160.244-84.066215.606778.358-163.434
Operating Income-564.063-443.61-536.201-267.824218.081-657.772
Free Cash Flow25.264-481.662-356.17-577.099-342.743-307.451
Free Cash Flow Per Share0.324-5.927-4.068-6.246-3.177-3.0708250099880146
EPS (Diluted) GAAP-7.11-5.153454-8.034445-5.8007422.338252-7.13
EPS Growth
EPS Non-GAAP
Gross Margin-45.459%-22.83%-9.01%17.341%40.923%-7.435%
Operating Margin-104.437%-63.202%-57.47%-21.541%11.466%-29.923%
Profit Margin-102.597%-59.665%-75.4%-43.108%12.368%-32.454%
Free Cash Flow Margin4.678%-68.624%-38.174%-46.415%-18.02%-13.9863%
Shares Outstanding (Diluted)77.95681.26287.55992.398107.875100.12
Shares Change (YoY)5.897%4.241%7.749%5.527%16.75%-7.189%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-05-06330.51Mn/a358.43M1.08%330.96M1.00%2.88121.92M653.19M838.16Mprocessed
2025 Q42026-03-02369.61Mn/a-411.58M-1.11%-282.85M-76.53%-2.70104.84M939.65M828.97Mprocessed
2025 Q32025-11-06370.04Mn/a-103.39M-27.94%-179.95M-48.63%-1.80100.24M850.99M1.04Bprocessed
2025 Q22025-08-06513.12Mn/a115.58M22.52%196.89M38.37%1.89106.62M800.14Mn/aprocessed
2025 Q12025-05-06611.52Mn/a-300.39M-49.12%-447.51M-73.18%-4.6097.36M522.76Mn/aprocessed
2024 Q42025-02-28638.16Mn/a161.68M25.34%159.05M24.92%1.20132.78M1.35B1.14Bprocessed
2024 Q32024-11-06429.77Mn/a22.20M5.16%33.61M7.82%0.34100.45M1.20B1.23Bprocessed
2024 Q22024-08-07360.55Mn/a-701.00K-0.19%6.46M1.79%0.0799.14M1.46B1.23Bprocessed
2024 Q12024-05-01359.48Mn/a34.91M9.71%36.12M10.05%0.3799.11M1.39B1.24Bprocessed
2023 Q42024-02-28365.07Mn/a24.62M6.75%45.66M12.51%0.44103.77M1.68B1.24Bprocessed
2023 Q32023-11-01309.32Mn/a-20.84M-6.74%-40.94M-13.23%-0.4688.89M1.73B1.24Bprocessed
2023 Q22023-08-02238.99Mn/a-133.52M-55.87%-23.94M-10.02%-0.2788.74M1.86B1.24Bprocessed
2023 Q12023-05-02231.50Mn/a-138.09M-59.65%-516.75M-2.23%-5.8688.19M1.88B1.23Bprocessed
2022 Q42023-02-28235.93Mn/a-106.83M-45.28%-109.24M-46.30%-0.31349.97M1.99B1.54Bprocessed
2022 Q32022-11-02207.77Mn/a-131.35M-63.22%-257.74M-1.24%-2.9487.63K2.07B1.54Bprocessed
2022 Q22022-08-02211.24Mn/a-211.13M-99.95%-231.48M-1.10%-2.6587.51K1.93B564.70Mprocessed
2022 Q12022-05-04188.82Mn/a-86.88M-46.01%-105.03M-55.62%n/a87.25K2.01B564.20Mprocessed
2021 Q42022-03-01178.72Mn/a-105.81M-59.20%-121.98M-68.25%-0.38324.81M2.55B563.67Mprocessed
2021 Q32021-11-03166.91Mn/a-34.46M-20.64%-48.14M-28.84%0.0779.88K2.04B563.14Mprocessed
2021 Q22021-08-04141.84Mn/a-167.57M-1.18%-81.41M-57.39%0.0779.75M1.73B562.61Mprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.